Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D005069:Evaluation Studies as Topic; D005472:Fluorouracil / Q000627:therapeutic use; D006918:Hydroxyurea / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D010879:Piperazines / Q000627:therapeutic use*; D011407:Propane / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D012513:Sarcoma, Experimental / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*
D000970:Antineoplastic Agents; D010879:Piperazines; D003520:Cyclophosphamide; D011407:Propane; D005472:Fluorouracil; D006918:Hydroxyurea; D008727:Methotrexate